Browse drugs

…ims Combination therapy with endoscopic band ligation (EBL) and propranolol (PPL) is the standard approach for secondary prevention of oeso…

…d controlled trials (figure 1), most of which showed that 0.01% atropine eyedrops have some myopia control effect. However, the efficacy…

… (OR 0.225; CI 0.051 to 0.990; p 0.048) and hydroxychloroquine (HCQ) (OR 0.293; CI 0.115 to 0.746; p 0.01) was associated with a lo…

…(49), and nervous system (39).Most frequently tested drugs were amoxicillin (14), furosemide (9) and levofloxacin (8). Based on 6-month sta…

…s evolved with the emergence of new therapeutic targets such as risankizumab. Plasma drug concentrations complement data directly related to…

…e of combination therapy (35.0%) was observed, while the use of fluoroquinolones decreased significantly (-31.1%). Despite the significant decre…

…tion therapy with anti-VEGF agents (aflibercept, bevacizumab or faricimab) and one eye received three treatments.The average number of ad…

…Background and Importance Trastuzumab deruxtecan (T-DXd) is an antibody–drug conjugate with proven efficacy in HER2-pos…

…edian age of 70 years (range 55-77).27.81% of patients received CL1.The anthropometric data of the patients were: median weight of …

…ults Thirty-seven patients were included; 97.3% (n=36) received dalbavancin off-label. The most frequent indications were prosthetic joint …

…cal scenarios (n=144) combining the main covariates influencing ibrutinib exposure. Under standard conditions (420 mg/day, fasting), pred…

…orer outcomes linked to low cyclophosphamide (mEFS 8 vs NA) and doxorubicin RDI (mPFS 7 vs 29 months).References and/or Acknowledgements 1.…